Dlx1/2 homeobox genes regulate retinal ganglion cell (RGC) differentiation by directly activating Brn3b. Triple knockout mice have near complete RGC loss with a marked increase in amacrine cells.
4A,B,J).
However, more cells were co-labelled with syntaxin and BrdU in the GCL (Fig. 
4E,F,K).
Similar results were observed in E13.5 as well as E16.5 birth-dated mutants (Fig. 
4C,D,G,H,J,K; data not shown).
Hence, in TKO retinas, most progenitors that exit mitosis migrate to the GCL and express amacrine rather than RGC markers.
Increased apoptosis and abnormal cell division in Dlx1/Dlx2/Brn3b null retinas At E13.5, the TKO had a significant 4-fold increase in apoptotic cells (70.5±11 of mutants versus 15.5±7 of WT, p<0.01, n=4; Fig. 5A ,B,G). However, for E16.5 and E18.5 TKO, apoptotic cell numbers were similar to WT (Fig. 5G) . In the TKO at E13.5, the majority of caspase-3+ cells were confined to the inner retina, where prospective RGCs are located.
Unlike the Brn3b SKO or Dlx1/Dlx2 DKO, enhanced apoptosis later than E13.5 was not detected in the TKO.
TKO retinas displayed a significant reduction (46% and 41%) in M-phase cells at E16.5 (Fig. 5D,H ) and E18.5, respectively (Fig. 5H) . Similarly, fewer S-phase cells were detected in E16.5 and E18.5 mutants (data not shown). Flow cytometry yielded concordant results at E16.5 and E18.5, with significantly reduced proportions of cells in S phase (p=0. 005, n=3) but changes in G2/M and G1/G0 phases were not significant (Fig. 5E,F,I ; data not shown).
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Expression of BRN3b and DLX2 in Atoh7 (Math5) null retinas
Math5/DLX2 co-expressing cells are present at E11.5 when DLX2 is first detected (Fig. 6 A-C), extending to E13.5 (Fig. 6 D-F) , but co-expression is absent at E18.5 (Fig. 6 E16 .5 G-I; E18.5 J-K). Math5 expression was unaffected in the Brn3b SKO, Dlx1/Dlx2 DKO and the TKO (Fig. 7a) . BRN3b expression was severely reduced in the Math5 -/-retina at E13.5
( Fig. 7b G,H ) and E16.5 ( Fig. 7b I,J) . However, DLX2 expression was significantly reduced at E13.5 (p=0.01, Fig. 7b A, B,E) but not significantly in the Math5 null GCL at E16.5, a time when Math5 expression is down-regulated (p=0.09, Fig. 7b C,D,F) . Interestingly, of the few BRN3b+ cells remaining in the Math5 -/-GCL at E16.5, a proportion co-express DLX2 (data not shown), supporting a role for DLX2 in promoting or maintaining Brn3b expression in the absence of Math5 function.
DLX1/DLX2 regulate Brn3b by specific binding to the Brn3b promoter in vivo
As development proceeds, more BRN3b cells express DLX2, and from E16.5, all BRN3b+ cells co-express DLX2 (Fig. S1) . We postulated that DLX1 and/or DLX2 regulate Brn3b transcription during retinogenesis. We used chromatin immunoprecipitation (ChIP) of embryonic retina and specific antibodies to detect DLX proteins localized to the Brn3b promoter region in vivo. Candidate regions were selected based on groups of putative TAAT/ATTA homeodomain consensus DNA-binding motifs. We focused on a region of the Brn3b promoter 2,263 bp upstream of the start codon. ChIP was performed by using PFA cross-linked cells prepared from E16.5 retina and hindbrain used as a negative tissue control (Zhou et al., 2004) . For PCR analysis we designated seven fragments as 3bP1-7. Only site 3bP4 was amplified from DLX1 or DLX2 immunoprecipitated DNA, supporting DLX1 and DLX2 occupancy of this Brn3b promoter region in E16.5 retina (Fig. 8a A,B) .
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Radiolabeled 3bP4 oligonucleotide fragments were incubated with recombinant DLX1/DLX2 proteins; we observed two specific protein-DNA band shifts as DLX1-3bP4
and DLX2-3bP4 complexes in electrophoretic mobility shift assays (EMSA) (Fig. 8a C,   lanes 2,7) . These bands were competitively inhibited by unlabeled 3bP4 probe (Fig. 8a C,   lanes 3,8) , and were "supershifted" by addition of specific DLX1 or DLX2 antibodies ( Fig.   8a C, lanes 4,9) . IgG was used as a control antibody (Fig. 8a C, lanes 5,10) .
We then performed transient co-transfection and site-directed mutagenesis assays. A plasmid expressing Dlx1, Dlx2, or both was co-transfected into HEK293 cells with a vector in which the Brn3b 3bP4 promoter region drives reporter gene expression. DLX1 and DLX2
co-transfection resulted in 2.1 and 2.5 fold increases of luciferase activity, respectively ( Fig.   8b ). Co-transfection of Dlx1 with Dlx2 yielded similar results to Dlx2 co-transfection alone (Fig. S4) . Mutations of any of the three candidate binding motifs within the 3bP4 promoter region significantly reduced luciferase activity by DLX1 and DLX2 in vitro, suggesting that DLX1 or DLX2 activation of 3bP4 promoter expression may occur via any one of these binding sites.
Brn3b expression is decreased by Dlx2 knockdown in primary embryonic retinal cultures
Primary cultures of WT E14.5 retina were transiently transfected with siRNA targeting the Dlx2 coding sequence or a scrambled control siRNA (de Melo et al., 2008) . There was efficient knockdown of Dlx2 mRNA, with a concomitant decrease of Brn3b mRNA expression, compared to the transfection of control siRNA and untreated cells (Fig. 8c ).
Taken together with the RGC phenotype of the Dlx1/Dlx2 DKO (de Melo et al., 2005) , these knockdown experiments support that Dlx2 function is necessary for Brn3b expression in situ.
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Gain of Dlx2 function in utero results in ectopic Brn3b expression in vivo
Gain-of-function assays in retinal explants are compromised by the loss of trophic support of RGCs due to optic nerve transection during tissue preparation (de Melo et al., 2008) .
Subsequently, we ectopically expressed Dlx2 in the intact embryo. E14.5 retinas were electroporated in utero with pCIG2-mCherry-Dlx2 ( Fig. 9A-G 
Regulation of Dlx2 expression by BRN3B is not mediated by direct interactions with
Dlx1/Dlx2 regulatory regions in vivo
Brn3b negatively regulates Dlx1 and Dlx2 in the embryonic retina (Mu et al., 2005; Qiu et al., 2008) . We observed a transient increase in DLX2 expression at E13.5 but not at E11.5 or E16.5 in the Brn3b SKO retina (Fig. S6) . Since RGC apoptosis occurs in Brn3b mutants at ~E15.5, the initial increase in DLX2 expression could be lost due to the ensuing cell death.
Repression of Dlx2 by BRN3b could occur earlier, during the peak of early-born RGC differentiation regulated by Atoh7-Brn3b. This repression is removed with diminishing Atoh7 expression after E16.5 (Brown et al., 1998) .
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We tested whether this negative regulation could be due to occupancy of Dlx1/Dlx2 regulatory regions by BRN3b. Cis-acting elements of the Dlx1/Dlx2 bigenic cluster include two intergenic enhancers, I12b and I12a, and two upstream regulatory elements (URE), URE1 and URE2 (Ghanem et al., 2003; Ghanem et al., 2007) (Fig. S7) as early as E11.5, reduced DLX2 expression in the Atoh7 KO at E13.5 ( Fig. 7) and report of a Dlx regulatory region as a direct ATH5 target in the chick retina (Del Bene et al., 2007) , we
propose that Atoh7-Brn3b/Isl1 and Atoh7-Dlx1/Dlx2-Brn3b regulate parallel transcriptional pathways for RGC differentiation (Fig. 10) . Math5/DLX2 co-expressing RPC could later co-express DLX2/BRN3B. Furthermore, downregulation of DLX2 by BRN3B in some RGC progenitors may be a mechanism underlying RGC sub-type specification. Lineage tracing and evaluation of cadherin 6 (De la Huerta et al., 2012) and other markers will contribute towards identifying a role for specific RGC subtypes. Deletion of both Isl1 and Brn3b would not affect RPC competence to become RGC, since Dlx1/Dlx2 would be available for promoting RGC differentiation. However, deletion of Dlx1/Dlx2 and Brn3b would block two of the more dominant pathways for RGC differentiation and survival. The few remaining RGC in Dlx1/Dlx2/Brn3b compound mutants could derive from the small population of Isl1 expressing progenitors (Fig. 1b H) , which are distinct from those expressing Brn3b (Moshiri et al., 2008) , although ISL1 also co-labels ChAT+ amacrine cells. Interestingly, these early born cholinergic amacrine cells also derive from Ath5-lineage cells (Jusuf et al., 2012) . ISL1
and BRN3B can cooperate to specify RGC cell fate (Li et al., 2014; Wu et al., 2015) .
In addition to early RGC loss, we found a significant increase in dislocated amacrine cells in the E18.5 TKO GCL. This result was unexpected, since only RGCs are affected by deletion of either Dlx1/Dlx2 or Brn3b (de Melo et al., 2005; Erkman et al., 1996; Gan et al., 1996) . A similar phenotype was reported in Atoh7 mutants, with increased cones, bipolar and and 1% penicillin/streptomycin. After 7 DIV, explants were fixed in 4% PFA for 30 minutes and sectioned. ChAT+ cells were counted at 120μm intervals and results were pooled.
Pulse Labeling and Birthdating
For pulse labeling, BrdU (100μg/g) was injected intraperitoneally (i.p.) to pregnant dams 1 hour before euthanasia. Sections were incubated in 50% formamide/2X SSC for 2 hr at 65°C
and 2N HCL for 30 min at 37°C, followed by 0.1 M Sodium Borate for 10 min at room temperature (RT).
Propidium Iodide (PI) Staining and Cell Cycle Analysis
Retinas were dissociated into single cell suspensions in 1X PBS and fixed in 70% Ethanol overnight at 4ºC. Cells were resuspended in 250μl PI (50μg/ml) and 1μl RNAse (20μg/ml), and incubated for 15 min at RT. Flow cytometry was performed on a FACSCalibur apparatus (Becton Dickinson), and analyzed using BD CellQuest Pro Version 3.5 software.
Cell Counting and Statistical Analysis
Cell counts were performed on paired WT and mutant retinas (de Melo et al., 2005) . For 
Microscopy and Imaging
Images were acquired using an Olympus BX51 microscope with a SPOT 1.3.0 digital camera (Diagnostic Instruments Inc., Sterling Heights, MI) or an Olympus DP70 digital camera.
Fluorescent images were acquired using an Olympus IX81 inverted microscope with a
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Fluoview FV500 confocal laser scanning system (Olympus Optical Co., Tokyo, Japan).
Images were processed using Adobe Photoshop software (Adobe Systems) for presentation.
Chromatin Immunoprecipitation and Electrophoretic Mobility Shift Assays
E16.5 retina tissues were isolated for ChIP assays as described previously (Zhou et al., 2004) .
Oligonucleotide primers for PCR amplification were designed according to the Brn3b For EMSA, the S4-pro region was excised from the pCR2.1-TOPO vector (Invitrogen) with EcoRI, and labeled with α-P 32 -dATP (Perkin Elmer) using the Klenow (large) Fragment of DNA PolI (Invitrogen). The binding reaction mixture contained labeled probes (90,000 cpm), binding buffer (20% glycerol, 5mM MgCl2, 2.5mM EDTA, 2.5mM DTT, 250mM
NaCl and 50mM Tris-HCl pH7.5), 1μg poly-dI-dC, and purified recombinant DLX1 or DLX2 protein, and was incubated for 30 min. at RT. 100-fold excess unlabeled probes were used for "cold competition" experiments; rabbit polyclonal DLX1 and DLX2 antibodies were used for "supershift" experiments; and a rabbit polyclonal antibody to mouse IgG (Jackson Immunoresearch) was used as a negative antibody control.
Cell Culture and Reporter Gene Assays
HEK-293 cells were grown in alpha DMEM (Gibco) with 10% FBS at 37°C with 5% CO2.
24 hours prior to transfection, cells were seeded at a density of 1x10 7 per 36 mm 2 dish.
Lipofectamine 2000 reagent (Invitrogen) was used for transient transfection. Reporter plasmids were constructed by inserting the 318 bp S4-pro fragment into the pGL3-basic vector (Promega). Putative DLX DNA binding sites in S4-pro were deleted respectively by site-directed mutagenesis using the Quick Change Kit (Stratagene); mutations (Δ1, Δ2 and Δ3)
